Johnson and Johnson Archives | Northwest Public Broadcasting

Why The Johnson & Johnson Vaccine Has Gotten A Bad Rap — And Why That’s Not Fair

By NPR News February 22, 2021

Kurtis Smith gives the Moderna coronavirus vaccine to a resident at Red Hook Neighborhood Senior Center in Brooklyn, N.Y., on Monday. CREDIT: Michael M. Santiago/Getty Images

In clinical trials, the Johnson & Johnson vaccine appears to be 66% effective at preventing moderate to severe cases of COVID-19 — compared to about 95% for Moderna and Pfizer. That has some people wondering if they should avoid the Johnson & Johnson vaccine. Absolutely not, says Dr. Ashish Jha, dean of the Brown University School of Public Health. Read More

Johnson & Johnson Data Show Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

By NPR News January 29, 2021

Prepared COVID-19 Pfizer-BioNTech vaccine syringes are seen at Edward Hospital in Naperville, Ill., Thursday, Dec. 17, 2020. Illinois received about 43,000 doses in its first shipment of a COVID-19 vaccine Monday as health officials reported another 103 coronavirus deaths statewide. Most of the shots will be distributed to local health care centers for health care workers, according to Illinois Gov. J.B. Pritzker's office. CREDIT: Nam Y. Huh/AP

The study was conducted in the U.S., Latin America and South Africa. The vaccine did better at preventing disease in the U.S. – 72% — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%. Read More

Johnson & Johnson Stops Selling Talc-Based Baby Powder In U.S. And Canada

By NPR News May 19, 2020

The company said demand has declined "fueled by misinformation around the safety of the product and a constant barrage of litigation advertising." Lawsuits allege the powder causes cancer. Continue Reading Johnson & Johnson Stops Read More

Several Drug Companies Considering Large Settlements To Resolve Opioid Suits

By NPR News August 28, 2019

Purdue Pharma and other health care giants are discussing potential deals with authorities that could resolve thousands of lawsuits they're facing over the U.S. opioid epidemic. Drew Angerer/Getty Images

Confronted with a torrent of lawsuits across the U.S., several major drug companies are in discussions with authorities to resolve thousands of opioid-related suits filed against them. A government source close to the negotiations tells NPR that Purdue Pharma, Johnson & Johnson, Endo International and Allergan are looking to cut deals. Read More